Reviva Pharmaceuticals Holdings, Inc. Cash
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Cash of $19.90 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-08-12
- 2026-06-30: Cash $19.90M.
- 2026-03-31: Cash $22.20M.
- 2025-12-31: Cash $14.40M.
- 2025-09-30: Cash $13.20M.
| Period end | Cash |
|---|---|
| 2026-06-30 | $19.90M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $22.20M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $14.40M 10-K · filed 2026-03-30 |
| 2025-09-30 | $13.20M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $10.40M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $5.30M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $13.50M 10-K · filed 2025-04-03 |
| 2024-09-30 | $5.60M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $6.20M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $12.00M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $23.40M 10-K · filed 2024-04-15 |
| 2023-09-30 | $5.00M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $11.20M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $11.30M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $18.50M 10-K · filed 2023-03-30 |
| 2022-09-30 | $23.20M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $19.40M 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |